Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier de Saint-Denis

About this trial

This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.

Eligibility criteria

Qualifiers

Adult patients (age ≥ 18 years)

Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023

Intubated and mechanically ventilated

Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia

Disqualifiers

Patients under 18 years old

Patients who refuse the use of their data for research purposes

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed